Related Articles
Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up
Durable response to lenalidomide in a patient with myelodysplastic syndrome associated with isolated 5q deletion and JAK2 V617F mutation despite discontinuation of treatment
Jumping translocations of 1q in donor cell‑derived myelodysplastic syndrome after cord blood transplantation: Case report and review of the literature
Acute pro‑B‑Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review
HYPERFIBROTIC MYELODYSPLASIA - A POSSIBLE NEW ENTITY (REVIEW)